Ovarian Granulosa Cells from Women with PCOS Express Low Levels of SARS-CoV-2 Receptors and Co-factors

Overview

Journal Arch Gynecol Obstet

Specialty Gynecology & Obstetrics

Date 2022 Apr 28

PMID 35477803

Authors

Aalaap Naigaonkar

Krutika Patil

Shaini Joseph

Indira Hinduja

Srabani Mukherjee

Affiliations

Soon will be listed here.

Abstract

Purpose: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is global pandemic with more than 5 million deaths so far. Female reproductive tract organs express coronavirus-associated receptors and factors (SCARFs), suggesting they may be susceptible to SARS-CoV-2 infection; however, the susceptibility of ovary/follicle/oocyte to the same is still elusive. Co-morbidities like obesity, type-2 diabetes mellitus, cardiovascular disease, etc. increase the risk of SARS-CoV-2 infection. These features are common in women with polycystic ovary syndrome (PCOS), warranting further scope to study SCARFs expression in ovary of these women.

Materials And Methods: SCARFs expression in ovary and ovarian tissues of women with PCOS and healthy women was explored by analyzing publically available microarray datasets. Transcript expressions of SCARFs were investigated in mural and cumulus granulosa cells (MGCs and CGCs) from control and PCOS women undergoing in vitro fertilization (IVF).

Results: Microarray data revealed that ovary expresses all genes necessary for SARS-CoV-2 infection. PCOS women mostly showed down-regulated/unchanged levels of SCARFs. MGCs and CGCs from PCOS women showed lower expression of receptors ACE2, BSG and DPP4 and protease CTSB than in controls. MGCs showed lower expression of protease CTSL in PCOS than in controls. Expression of TMPRSS2 was not detected in both cell types.

Conclusion: Human ovarian follicle may be susceptible to SARS-CoV-2 infection. Lower expression of SCARFs in PCOS indicates that the risk of SARS-CoV-2 infection to the ovary may be lesser in these women than controls. This knowledge may help in safe practices at IVF settings in the current pandemic.

Citing Articles

Unraveling the Role of Cathepsin B Variants in Polycystic Ovary Syndrome: Insights from a Case-Control Study and Computational Analyses.

Akbar-Abad M, Majidpour M, Sargazi S, Ghasemi M, Saravani R Reprod Sci. 2025; .

PMID: 40044993 DOI: 10.1007/s43032-025-01806-w.

The effect of COVID-19 and COVID-19 vaccination on serum anti-Mullerian hormone: A systematic review and meta-analysis.

Ghaemi M, Hantoushzadeh S, Shafiee A, Kohandel Gargari O, Fathi H, Eshraghi N Immun Inflamm Dis. 2024; 12(1):e1136.

PMID: 38270314 PMC: 10777886. DOI: 10.1002/iid3.1136.

Does Coronavirus Disease-19 Infection Affect Ovarian Reserve in Infertile Women? A Retrospective Study.

Kahyaoglu S, Ozaksit M, Kahyaoglu I, Filiz A, Kuru Pekcan M, Atalay E J Hum Reprod Sci. 2023; 15(4):357-361.

PMID: 37033136 PMC: 10077751. DOI: 10.4103/jhrs.jhrs_121_22.

References

Yue H, Bai X, Wang J, Yu Q, Liu W, Pu J . Clinical characteristics of coronavirus disease 2019 in Gansu province, China. Ann Palliat Med. 2020; 9(4):1404-1412. DOI: 10.21037/apm-20-887. View

Mohammadi E, Shafiee F, Shahzamani K, Ranjbar M, Alibakhshi A, Ahangarzadeh S . Novel and emerging mutations of SARS-CoV-2: Biomedical implications. Biomed Pharmacother. 2021; 139:111599. PMC: 8062574. DOI: 10.1016/j.biopha.2021.111599. View

Marselli L, Piron A, Suleiman M, Colli M, Yi X, Khamis A . Persistent or Transient Human β Cell Dysfunction Induced by Metabolic Stress: Specific Signatures and Shared Gene Expression with Type 2 Diabetes. Cell Rep. 2020; 33(9):108466. DOI: 10.1016/j.celrep.2020.108466. View

Strollo R, Pozzilli P . DPP4 inhibition: Preventing SARS-CoV-2 infection and/or progression of COVID-19?. Diabetes Metab Res Rev. 2020; 36(8):e3330. PMC: 7267128. DOI: 10.1002/dmrr.3330. View

Romek M, Gajda B, Krzysztofowicz E, Smorag Z . Changes of lipid composition in non-cultured and cultured porcine embryos. Theriogenology. 2010; 74(2):265-76. DOI: 10.1016/j.theriogenology.2010.02.010. View

Virant-Klun I, Strle F . Human Oocytes Express Both ACE2 and BSG Genes and Corresponding Proteins: Is SARS-CoV-2 Infection Possible?. Stem Cell Rev Rep. 2021; 17(1):278-284. PMC: 7785127. DOI: 10.1007/s12015-020-10101-x. View

Stanley K, Thomas E, Leaver M, Wells D . Coronavirus disease-19 and fertility: viral host entry protein expression in male and female reproductive tissues. Fertil Steril. 2020; 114(1):33-43. PMC: 7205710. DOI: 10.1016/j.fertnstert.2020.05.001. View

Smedts A, Lele S, Modesitt S, Curry T . Expression of an extracellular matrix metalloproteinase inducer (basigin) in the human ovary and ovarian endometriosis. Fertil Steril. 2006; 86(3):535-42. DOI: 10.1016/j.fertnstert.2006.01.042. View

Monte G, Murisier F, Piva I, Germond M, Marci R . Focus on intracytoplasmic morphologically selected sperm injection (IMSI): a mini-review. Asian J Androl. 2013; 15(5):608-15. PMC: 3881647. DOI: 10.1038/aja.2013.54. View

10.

Man L, Lustgarten-Guahmich N, Kallinos E, Redhead-Laconte Z, Liu S, Schattman B . Comparison of Human Antral Follicles of Xenograft versus Ovarian Origin Reveals Disparate Molecular Signatures. Cell Rep. 2020; 32(6):108027. DOI: 10.1016/j.celrep.2020.108027. View

11.

Morelli F, Meirelles L, de Souza M, Mari N, Mesquita C, Dartibale C . COVID-19 Infection in the Human Reproductive Tract of Men and Nonpregnant Women. Am J Trop Med Hyg. 2021; 104(3):814-825. PMC: 7941816. DOI: 10.4269/ajtmh.20-1098. View

12.

Essahib W, Verheyen G, Tournaye H, Van de Velde H . SARS-CoV-2 host receptors ACE2 and CD147 (BSG) are present on human oocytes and blastocysts. J Assist Reprod Genet. 2020; 37(11):2657-2660. PMC: 7505486. DOI: 10.1007/s10815-020-01952-x. View

13.

Dumesic D, Meldrum D, Katz-Jaffe M, Krisher R, Schoolcraft W . Oocyte environment: follicular fluid and cumulus cells are critical for oocyte health. Fertil Steril. 2014; 103(2):303-16. DOI: 10.1016/j.fertnstert.2014.11.015. View

14.

Jing Y, Run-Qian L, Hao-Ran W, Hao-Ran C, Ya-Bin L, Yang G . Potential influence of COVID-19/ACE2 on the female reproductive system. Mol Hum Reprod. 2020; 26(6):367-373. PMC: 7239105. DOI: 10.1093/molehr/gaaa030. View

15.

Li S, Li S, Disoma C, Zheng R, Zhou M, Razzaq A . SARS-CoV-2: Mechanism of infection and emerging technologies for future prospects. Rev Med Virol. 2022; 31(2):e2168. DOI: 10.1002/rmv.2168. View

16.

Morgante G, Troia L, De Leo V . Coronavirus Disease 2019 (SARS-CoV-2) and polycystic ovarian disease: Is there a higher risk for these women?. J Steroid Biochem Mol Biol. 2020; 205:105770. PMC: 7550902. DOI: 10.1016/j.jsbmb.2020.105770. View

17.

Subramanian A, Anand A, Adderley N, Okoth K, Toulis K, Gokhale K . Increased COVID-19 infections in women with polycystic ovary syndrome: a population-based study. Eur J Endocrinol. 2021; 184(5):637-645. PMC: 8052516. DOI: 10.1530/EJE-20-1163. View

18.

Deng Q, Rasool R, Russell R, Natesan R, Asangani I . Targeting androgen regulation of TMPRSS2 and ACE2 as a therapeutic strategy to combat COVID-19. iScience. 2021; 24(3):102254. PMC: 7919514. DOI: 10.1016/j.isci.2021.102254. View

19.

Wettenhall J, Smyth G . limmaGUI: a graphical user interface for linear modeling of microarray data. Bioinformatics. 2004; 20(18):3705-6. DOI: 10.1093/bioinformatics/bth449. View

20.

Adams J, Liu Z, Ren Y, Wun W, Zhou W, Kenigsberg S . Enhanced Inflammatory Transcriptome in the Granulosa Cells of Women With Polycystic Ovarian Syndrome. J Clin Endocrinol Metab. 2016; 101(9):3459-68. PMC: 5010574. DOI: 10.1210/jc.2015-4275. View